<0.001 EU per 1 μg of the peptide by the LAL method
For reduction of mortality in patients with severe sepsis.
Examples of Clinical Use:
The product is activated human protein C that is synthesized by recombinant DNA technology. It is a glycoprotein of approximately 55 kilodalton molecular weight, consisting of a heavy chain and a light chain linked by a disulfide bond. The product inhibits factor Va and VIIIa, thereby reducing the coagulability of blood.
Mechanism of action:
Activated protein C combines with protein S on platelet surfaces and then degrades factor Va and factor VIIIa, thereby reducing blood coagulability.
For research use only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products
without prior written approval from Creative BioMart.
For more information on how our products could help advance your project, please contact us.